RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets
Year: 2015
Type: article
Abstract: There is no currently licensed vaccine for respiratory syncytial virus (RSV) despite being the leading cause of lower respiratory tract infections in children. Children previously immunized with a formalin-inactivated RSV (FI-RSV) vaccine exhibited enhanced respiratory disease following natural RSV infection. Subsequent studies in animal models have implicated roles for CD4 T cells, eosinophils and non-neutralizing antibodies in mediating enhanced respiratory disease. However, the underlying immunological mechanisms responsible for the enhanced respiratory disease and other disease manifestations associated with FI-RSV vaccine-enhanced disease remain unclear. We demonstrate for the first time that while CD4 T cells mediate all aspects of vaccine-enhanced disease, distinct CD4 T cell subsets orchestrate discrete and specific disease parameters. A Th2-biased immune response, but not eosinophils specifically, was required for airway hyperreactivity and mucus hypersecretion. In contrast, the Th1-associated cytokine TNF-α was necessary to mediate airway obstruction and weight loss. Our data demonstrate that individual disease manifestations associated with FI-RSV vaccine-enhanced disease are mediated by distinct subsets of CD4 T cells.
Source: PLoS Pathogens
Institution: University of Iowa
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Keywords: respiratory syncytial virus, formalin-inactivated RSV vaccine, vaccine-enhanced disease, CD4+ T cell subsets, Th2 immune response, Th1 response, TNF-α, airway hyperresponsiveness, mucus hypersecretion, eosinophils, non-neutralizing antibodies, airway obstruction, weight loss, respiratory syncytial virus infection
Open Access status: gold
Estimated APC paid: $3,043
OpenAlex ID: W2148326845
